LXGEST-200 SR Tablets

MRP - 3,200.00

Lxgest-200 SR contains Progesterone Sustained Release 200 mg, supporting luteal phase defects, dysfunctional uterine bleeding, and hormonal therapy needs. Manufactured by ISO & WHO-GMP certified Lxir Medilabs. A versatile women’s health choice for PCD pharma franchise partners expanding their gynaecology range. Rx only — use under medical supervision.

Brand NameLxgest-200 SR
CompositionProgesterone Sustained Release 200mg
Pack Size10 X 1 X 10
Pack TypeBlister
Start Chat
Category:

Description

Lxgest-200 SR — Sustained-Release Progesterone Built for a Fit and Fine Gestation

Lxgest-200 SR contains Progesterone Sustained Release 200 mg, formulated to support women through critical phases of reproductive health. Clinical use of this molecule has been associated with significantly prolonged pregnancy and increased birth weight in cases of threatened preterm birth, giving obstetricians a meaningful tool for high-risk pregnancy management. Compared to natural progesterone, this sustained-release form offers better bioavailability, fewer side effects and more convenient administration, making it a relevant choice for luteal phase support, dysfunctional uterine bleeding, hormonal therapy and premenstrual syndrome. This breadth of application across obstetrics and gynaecology gives franchise partners a genuinely versatile women’s health molecule.

Sustained-Release Precision Backed by Certified Manufacturing

Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. A sustained-release progesterone tablet demands tight control over release kinetics to maintain steady hormone levels over time and Lxgest-200 SR is manufactured under strict quality protocols to ensure this consistency across every batch. For a PCD pharma franchise company in India, offering a dependable progesterone SR formulation gives field partners a strong proposition for gynaecologists and obstetricians managing pregnancy support and hormonal therapy cases.

Product Highlights for Franchise Partners

  • Composition: Progesterone Sustained Release 200 mg
  • Dosage Form: Tablets
  • Indications: Luteal support in luteal phase defects, dysfunctional uterine bleeding, hormonal therapy, premenstrual syndrome
  • Key Benefit: Nurturing new life, every step of the way
  • Suited For: Distributors and medical representatives expanding their gynaecology and women’s health range

Franchise partners looking to add a sustained-release progesterone formulation to their portfolio can explore this and other products through our PCD pharma franchise division, with complete launch support.

Disclaimer: This is a prescription hormonal product and should be used strictly under the supervision of a registered medical practitioner.

Additional information

Brand Name

Lxgest-200 SR

Composition

Progesterone Sustained Release 200mg

Pack Size

10 X 1 X 10

Pack Type

Blister